Lithium perhydroantamanide complex (2:1): exposure of the peptide backbone in the analog of antamanide with antitoxic impotency.
The synthetic analog of antamanide in which all four phenylalanyl residues are hydrogenated to cyclohexylalanyl (Cha) residues, cyclic(Val-Pro-Pro-Ala-Cha-Cha-Pro-Pro-Cha-Cha), has a complete loss of antitoxic potency despite its ability to form ion complexes in the same manner as antamanide. The co...
Na minha lista:
| Publicado no: | Proc Natl Acad Sci U S A |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
National Academy of Sciences
1985
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC390807/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3864151/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.82.21.7155 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|